ONL Therapeutics

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. The current market for retinal drugs is greater than $7 billion and rapidly growing. Existing therapies have significant limitations and none address the initial neural component of vision loss - the death of the photoreceptor cell.